Cargando…

Effect of Vitamin D Supplementation on Outcomes in People With Early Psychosis: The DFEND Randomized Clinical Trial

IMPORTANCE: People with psychotic disorders have an increased risk of vitamin D deficiency, which is evident during first-episode psychosis (FEP) and associated with unfavorable mental and physical health outcomes. OBJECTIVE: To examine whether vitamin D supplementation contributes to improved clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaughran, Fiona, Stringer, Dominic, Wojewodka, Gabriella, Landau, Sabine, Smith, Shubulade, Gardner-Sood, Poonam, Taylor, David, Jordan, Harriet, Whiskey, Eromona, Krivoy, Amir, Ciufolini, Simone, Stubbs, Brendon, Casetta, Cecilia, Williams, Julie, Moore, Susan, Allen, Lauren, Rathod, Shanaya, Boardman, Andrew, Khalifa, Rehab, Firdosi, Mudasir, McGuire, Philip, Berk, Michael, McGrath, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715346/ https://www.ncbi.nlm.nih.gov/pubmed/34962559 http://dx.doi.org/10.1001/jamanetworkopen.2021.40858

Ejemplares similares

Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial
por: Gaughran, Fiona, et al.
Publicado: (2020)

Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study
por: Casetta, Cecilia, et al.
Publicado: (2020)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity
por: Lowe, Penelope, et al.
Publicado: (2017)

T183. LOW LEVELS OF VITAMIN D ARE ASSOCIATED WITH REDUCED CORTICAL THICKNESS AND SURFACE AREA IN FRONTAL, TEMPORAL AND OCCIPITAL REGIONS IN FIRST-EPISODE PSYCHOSIS PATIENTS
por: Ciufolini, Simone, et al.
Publicado: (2020)

Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

Clozapine haematological monitoring for neutropenia: a global perspective
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

O5.2. PREDICTORS OF CARDIOMETABOLIC RISK IN THE YEAR AFTER ONSET OF PSYCHOSIS: A PROSPECTIVE COHORT STUDY
por: Gaughran, Fiona, et al.
Publicado: (2018)

Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis
por: Green, Alastair, et al.
Publicado: (2019)

Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation
por: Keshavarzi, Farinaz, et al.
Publicado: (2020)

Dietary intake, physical activity and sedentary behaviour patterns in a sample with established psychosis and associations with mental health symptomatology
por: Martland, Rebecca, et al.
Publicado: (2023)

Mental health law in India: origins and proposed reforms
por: Firdosi, Muhammad Mudasir, et al.
Publicado: (2016)

Facilitated early discharge in Wandsworth
por: Firdosi, Mudasir, et al.
Publicado: (2021)

Length of stay in a home treatment team
por: Firdosi, Mudasir, et al.
Publicado: (2021)

New-onset psychosis due to COVID-19
por: Kozato, Nana, et al.
Publicado: (2021)

Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Rehabilitation or Stagnation? a Six Month Mirror-Image Study Reviewing the Effectiveness of an Inpatient Rehabilitation Unit
por: Kapila, Adisha, et al.
Publicado: (2022)

T147. CAN HIGH INTENSITY INTERVAL TRAINING (HIIT) IMPROVE PHYSICAL AND MENTAL HEALTH OUTCOMES? A META-REVIEW OF THE GLOBAL BENEFITS OF HIIT AND FOCUSED SYSTEMATIC REVIEW OF THE EFFECTS OF HIIT IN MENTAL DISORDERS
por: Martland, Rebecca, et al.
Publicado: (2020)

Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis
por: Taylor, David, et al.
Publicado: (2022)

Resolution without discontinuation: heart failure during clozapine treatment
por: Whiskey, Eromona, et al.
Publicado: (2020)

‘Walk This Way’ – a pilot of a health coaching intervention to reduce sedentary behaviour and increase low intensity exercise in people with serious mental illness: study protocol for a randomised controlled trial
por: Williams, Julie, et al.
Publicado: (2016)

M189. A PILOT RANDOMISED CONTROLLED TRIAL TO ASSESS THE FEASIBILITY AND ACCEPTABILITY OF HIGH INTENSITY INTERVAL TRAINING (HIIT) AMONG INPATIENTS WITH SEVERE MENTAL ILLNESS (SMI)
por: Martland, Rebecca, et al.
Publicado: (2020)

Study protocol for a pilot high-intensity interval training intervention in inpatient mental health settings: a two-part study using a randomised controlled trial and naturalistic study design
por: Martland, Rebecca, et al.
Publicado: (2021)

Perspectives on implementing HIIT interventions for service users in inpatient mental health settings: a qualitative study investigating patient, carer and staff attitudes
por: Martland, Rebecca, et al.
Publicado: (2021)

Clinical correlates of vitamin D deficiency in established psychosis
por: Lally, J., et al.
Publicado: (2016)

Clozapine and COVID-19
por: Silva, Edward, et al.
Publicado: (2020)

Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism
por: Kočovská, Eva, et al.
Publicado: (2017)

Possible pharmacogenetic factors in clozapine treatment failure: a case report
por: Whiskey, Eromona, et al.
Publicado: (2021)

A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
por: Livermore, Cecilia, et al.
Publicado: (2022)

Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
por: Rodriguez, Victoria, et al.
Publicado: (2020)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study
por: Gaughran, Fiona, et al.
Publicado: (2019)

Lower Bone Mineral Density at the Hip and Lumbar Spine in People with Psychosis Versus Controls: a Comprehensive Review and Skeletal Site-Specific Meta-analysis
por: Gomez, Lucia, et al.
Publicado: (2016)

Serum Prolactin and Bone Mineral Density in Schizophrenia: A Systematic Review
por: Lally, John, et al.
Publicado: (2019)

HbA1c recording in patients following a first diagnosis of serious mental illness: the South London and Maudsley Biomedical Research Centre case register
por: Bell, Nikeysha, et al.
Publicado: (2023)

Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals
por: Oloyede, Ebenezer, et al.
Publicado: (2021)

Outcomes of Pre-Existing Diabetes in People With/without New Onset Severe Mental Illness: A Primary-Secondary Mental Healthcare Linkage in South London, United Kingdom
por: Bell, Nikeysha, et al.
Publicado: (2023)

Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT)
por: Gaughran, Fiona, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nfhb6khlc4i72rols6p4v2f050